ARTICLES BY RAY SISON

  • Red-Green-apples-GettyImages-108514857
    CDMO Selection In Our Post-COVID World
    10/28/2022

    In a post-pandemic world, we need to explore a broader view of our new reality. This article shares some of the concepts currently playing out in bio/pharmaceutical outsourcing that will impact your CDMO selection strategy. Additional discussion touches on how new outsourcing players will fit in and the path forward.

  • Football-iStock-471466855
    CDMO Selection: How To Kick Off A Game-Winning Project
    11/1/2019

    This article explores the execution phase of outsourcing with a focus on the context and planning of the kickoff meeting. At this meeting, the handoff from the existing procurement team to the operations team will require close attention.

  • Three-3-Question-Marks-iStock-547531672
    CDMO Selection: 3 Questions To Save Time And Reduce Stress When Reviewing An MSA
    4/9/2019

    Whether because of unfamiliarity or lack of resources, master service or supply agreement (MSA) execution can be time consuming and difficult. 

Ray-Sison-xCell

Ray Sison

Ray Sison is VP of pharmaceutical outsourcing and tech transfer at xCell Strategic Consulting and principal consultant at Vinco Pharma Solutions. He began consulting in 2011 after recognizing a need for expertise in pharmaceutical outsourcing among the discovery- and clinical-stage pharma companies he served as a business development representative for Patheon and MDS Pharma Services. Based on his experience, Sison provides insight to the CDMO’s business and operations, helping his clients negotiate and achieve better outcomes. Additionally, he has developed sound processes and templates to streamline CMO procurement to save time and cost. You can reach him at rsison@xcellstrategicconsulting.com or connect with him on LinkedIn.